scholarly article | Q13442814 |
P50 | author | Aldo Quattrone | Q56862866 |
Paolo Girlanda | Q57035158 | ||
Patrizio Pasqualetti | Q40032361 | ||
Maria Trojano | Q41721876 | ||
Alessandra Lugaresi | Q41721881 | ||
Ugo Nocentini | Q46133541 | ||
Maria Fara De Caro | Q47504485 | ||
Giuseppe Salemi | Q47504554 | ||
P2093 | author name string | G Tedeschi | |
P Valentino | |||
G Savettieri | |||
D Farina | |||
C Caltagirone | |||
S Bonavita | |||
A Reggio | |||
F Le Pira | |||
M Buccafusca | |||
P2860 | cites work | Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. | Q50875866 |
Changes of attention and memory in a group of patients with multiple sclerosis. | Q51954309 | ||
Automatic and controlled information processing in multiple sclerosis. | Q52022827 | ||
Information processing speed in patients with multiple sclerosis. | Q52064788 | ||
Validity of some neuropsychological tests in the assessment of mental deterioration | Q52106915 | ||
Cognitive disturbances in patients with relapsing remitting multiple sclerosis. | Q52113272 | ||
Cognitive impairment in patients with multiple sclerosis and mild physical disability. | Q52256834 | ||
Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 | ||
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 | ||
An Inventory for Measuring Depression | Q26778503 | ||
Cognitive dysfunction in multiple sclerosis: a review of recent developments | Q28186881 | ||
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years | Q28191390 | ||
Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction | Q28276538 | ||
Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study | Q33591681 | ||
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. | Q34253953 | ||
New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
Minimal neuropsychological assessment of MS patients: a consensus approach | Q35073778 | ||
Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation | Q35453717 | ||
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis | Q35462222 | ||
Neuropsychological deficits in multiple sclerosis after acute relapse | Q36318073 | ||
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery | Q36836629 | ||
Neuropsychologic status in multiple sclerosis after treatment with glatiramer | Q38450118 | ||
Neuropsychological aspects of multiple sclerosis: a quantitative review | Q40864839 | ||
The prevalence of cognitive impairment in a community survey of multiple sclerosis | Q41822037 | ||
Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? | Q44794717 | ||
Donepezil improved memory in multiple sclerosis in a randomized clinical trial | Q45144727 | ||
Constructional apraxia in left brain-damaged patients: a planning disorder? | Q48286491 | ||
Analysis of impairment related functional architecture in MS patients during performance of different attention tasks | Q48332262 | ||
A modified card sorting test sensitive to frontal lobe defects | Q48346552 | ||
Speed of information processing in patients with multiple sclerosis | Q48425874 | ||
P433 | issue | 1 | |
P921 | main subject | multiple sclerosis | Q8277 |
cognitive dysfunction | Q57859955 | ||
relapsing-remitting multiple sclerosis | Q18555066 | ||
P304 | page(s) | 77-87 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
P1476 | title | Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis | |
P478 | volume | 12 |